latest update:
[TrialBase DB]

trial summary · NCT07835308

Bayesian Optimization of DBS for Gait

Trial record from the TrialBase DB dataset, status RECRUITING, condition Parkinson Disease (PD), sponsored by University of Minnesota. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07835308phase EARLY_PHASE1enrollment 15start 2026-12

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

This project aims to establish the feasibility of Bayesian optimization for tuning deep brain stimulation (DBS) to treat gait symptoms in Parkinson's disease (PD) patients. Our primary question is: Can Bayesian optimization of DBS achieve reproducible results within a feasible number of gait measurements? PD patients will be enrolled who have DBS of the subthalamic nucleus (STN) or globus pallidus (GP) in whom at least 3 months have passed since activation of their neurostimulators, for stabilization of clinical stimulator settings. We will apply Bayesian optimization to derive DBS settings which maximally lengthen step length relative to the OFF DBS state.

Source record: https://clinicaltrials.gov/study/NCT07835308

Facts

registry idNCT07835308
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phaseEARLY_PHASE1
study typeINTERVENTIONAL
lead conditionParkinson Disease (PD)
sponsorUniversity of Minnesota
sponsor classOTHER
enrollment15
start date2026-12
primary completion2031-03
completion2033-03
results postednot reported

Conditions

  • Parkinson Disease (PD)

Interventions

  • Deep Brain Stimulation

Countries

  • United States

Intervention types: OTHER

Work with this record